clinical trial of Qingfei Paidu granule for treatment of COVID-19 in childre
Not Applicable
- Conditions
- COVID-19
- Registration Number
- ITMCTR2200005962
- Lead Sponsor
- Shanghai Children's Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
1) Aged 3 ~ 18 years old;
2) Coincidence the diagnostic criteria of the diagnosis and treatment plan for pneumonia infected by COVID-19 (trial version 9);
3) mild/ common/ asymptomatic COVID-19 infection;
4) The informed consent process complies with the regulations, and the legal guardian and/ or the test child (= 8 years old) jointly sign the ICF.
Exclusion Criteria
1) Be are allergic to the test drug and intolerant to the drug;
2) cant ensure medication compliance during treatment and are difficult to give drugs by oral administration;
3) With basic respiratory diseases, malignant tumors, mental diseases and other malignant diseases of the system.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method egative time of COVID-19 nucleic acid test;
- Secondary Outcome Measures
Name Time Method hospital days;